News, insight, events and case studies

As we reflect on 2021, the ApolloLIMS team has noticed some interesting developments in the diagnostics space. The combination of the COVID-19 pandemic along with some other general developments within the biotech sector overall have combined to impact the diagnostic space for the better. The last year has been an exciting time to partner with […]

14 December 2021

We review 2021 and considers how the ongoing impact of Covid-19 and the rapid formation of pathology networks will impact the company in 2022. He also pauses to unwrap a ‘Christmas present’; the VUE diagnostic console that enables clinicians to report and view test results alongside many other sources of patient information.

9 December 2021

The Value of Coordinated Orders and Results Management for Outreach & Ambulatory Laboratory Testing. Extending lab reach beyond hospital walls works best with the integration of specialized surrounding solutions.

11 October 2021

In 2019, CliniSys | MIPS launched its Genetics LIS, with a successful phase of development and deployment in Europe. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genetics Counselling to clinicians, laboratories, patients and their families.

28 September 2021

Kim Futrell, MT(ASCP), MSHI Get more benefits from your point-of-care testing (POCT) program The advantage of quick test results to enable faster clinical decisions is one of the major reasons to implement point-of-care testing (POCT). At a time when hospitals and laboratories are under intense pressure, the benefits of patients accessing tests outside the traditional […]

30 August 2021

Last year, CliniSys brought its genomics LIMS to the UK, following a successful phase of development and deployment on the continent. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genomics Clinical to clinicians, laboratories, patients and their families

16 August 2021

In our Part 1 of this blog series, we discussed the changes we are anticipating in the centralized testing model for COVID-19. There are some changes in store for the COVID-19 diagnostics market driven by the increase in the number of recent authorizations by the US Food and Drug Administration (FDA) for point-of-care (and point of need) […]

17 June 2021

The United States is reaching a transition point in the COVID-19 pandemic due to a rise in the SARS-CoV-2-immune population (via vaccination or infection) and the onset of warmer weather. As a result, the COVID-19 cases in the United States are expected to decrease over the next few months. However, this year’s autumn and winter […]

9 June 2021

CliniSys Group has created a single brand for the UK and Europe, with a new website, colour palette and logo. What does it all mean for us, our customers and business partners? Michael Simpson, Group Chief Executive Officer explains. Hello and welcome to the new CliniSys | MIPS website! A single name brand for CliniSys […]

18 March 2021

The Integrated Clinical Environment, or ICE, is used in seven out of the 14 health boards in Scotland for order communications and results reporting. Imagine if it was used across Scotland, as a single point of information about tests of all kinds… At a recent webinar, CliniSys | MIPS outlined the art of the possible. […]

9 March 2021

In February, the Biden administration released its National Strategy for the COVID-19 Response and Pandemic Preparedness, which outlines seven goals that address a domestic response and global response to the current COVID-19 pandemic and prepare for future health-related threats. Foundationally, the plan’s goals revolve around establishing a science-based approach to countermeasures against the COVID-19 pandemic that […]

9 March 2021

We caught up with one of our GLIMS Project Managers, Richard Mertens, to find out more about his work at CliniSys | MIPS and what he most enjoys about his role.

2 March 2021